Combination of PI3K/Akt Pathway Inhibition and Plk1 Depletion Can Enhance Chemosensitivity to Gemcitabine in Pancreatic Carcinoma
The prognosis of pancreatic cancer (PC) remains pessimistic because of the difficulty in early diagnosis as well as the little advance in chemotherapy. Although being the first-line chemotherapy drug for PC at present, gemcitabine still has some disadvantages, such as low drug sensitivity and signif...
Main Authors: | Yonghuan Mao, Ling Xi, Quan Li, Sheng Wang, Zeling Cai, Xinhua Zhang, Chunzhao Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523318301062 |
Similar Items
-
Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
by: Sheng Wang, et al.
Published: (2021-03-01) -
LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
by: Xianbin Zhang, et al.
Published: (2019-11-01) -
Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
by: Wei-Tian Wei, Hui Chen, Zhao-Hong Wang, Zhong-Lin Ni, Hai-Bin Liu, Hong-Fei Tong, Hong-Chun Guo, Dian-Lei Liu, Sheng-Zhang Lin
Published: (2012-01-01) -
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
by: Daniela Massihnia, et al.
Published: (2017-01-01) -
Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells
by: Hai-Bo Xing, et al.
Published: (2018-01-01)